WHERE DIGITAL INNOVATION IMPROVES DEVELOPMENTAL TOXICOLOGY
VISION
Changing the way the world thinks about testing drugs for maternal and fetal safety
Reproductive toxicology testing for novel substances should be reproducible, efficient, accurate and secure. It should be nonbinary and allow artificial intelligence enhanced pattern recognition, predict drug interactions, and differentiate spontaneous mutations from those caused by chemical exposure.
THE DIFFERENCE
OUR
METHOD
Our work empowers innovative digital techniques for evaluating maternal and fetal safety profiles of drugs and chemicals. The TIO process produces quantitative data at near micron level, allowing pattern prediction and better evaluation of drug interactions.
WHY USE TIO
DECREASED LIABILITY EXPOSURE
Better data and better analytic tools protect from future liability. Predictive analytics suggest efficient testing for critical interactions between compounds. Owning secure data allows look back studies to update safety sheets and defend future liability claims.
